Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T20:02:52.288Z Has data issue: false hasContentIssue false

Pimozide: Adverse Reaction and Prolonged Half-Life

Published online by Cambridge University Press:  29 January 2018

F. A. Logan
Affiliation:
Gartnaval Royal Hospital, Glasgow
R. N. Herrington
Affiliation:
Gartnaval Royal Hospital, Glasgow
M. M. S. Mackie
Affiliation:
Dumfries and Galloway Royal Infirmary
P. C. Rubin
Affiliation:
Glasgow University, Stobhill General Hospital, Glasgow G21 3UW
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1982 

References

Griffin, J. P. & D'Arcy, P. F. (1979) Adverse Drug Interactions. Bristol: Wright.Google Scholar
McCreadie, R. G., Heykants, J. J. P., Chalmers, A. & Anderson, A. M. (1979) Plasma pimozide profiles in chronic schizophrenics. British Journal of Clinical Pharmacology, 7, 533–4.CrossRefGoogle ScholarPubMed
Mahgoub, A., Idle, J. R., Dring, L. G., Lancaster, R. & Smith, R. L. (1977) The polymorphic hydroxylation of debrisoquine in man. Lancet, 584–6.Google Scholar
Michiels, L. J. M., Heykants, J. J. P., Knaeps, A. G. & Janssen, P. A. J. (1975) Radioimmunoassay of the neuroleptic drug pimozide. Life Sciences, 16, 937–44.Google Scholar
Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., Spencer, R. & Avery, G. S. (1976) Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs, 12, 140.CrossRefGoogle ScholarPubMed
Soudijn, W. & Van Wijngaarden, I. (1969) The metabolism and excretion of the neuroleptic drug pimozide. Life Sciences, 8, 291–6.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.